Cross-source evidence timeline
Apraglutide research timeline
Follow 8 selected, directly cited source records from October 24, 2024 through August 4, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT07742735↗
PeptideScanner retained ClinicalTrials.gov record NCT07742735 at 2026-11-16T01:47:19.543Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT05706623↗
PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05018286↗
PeptideScanner retained ClinicalTrials.gov record NCT05018286 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04964986↗
PeptideScanner retained ClinicalTrials.gov record NCT04964986 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-06-18, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT04627025↗
PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04699032↗
PeptideScanner retained ClinicalTrials.gov record NCT04699032 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06002555↗
PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05995704↗
PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.↗
Added to PeptideScanner November 16, 2026